In the dynamic field of drug discovery, heterocyclic compounds play a pivotal role due to their diverse biological activities. 6,7-Dimethoxy-3,4-dihydroquinazolin-4-one (CAS: 13794-72-4) stands out as a valuable molecule for researchers aiming to develop new pharmaceuticals. As a key intermediate and research chemical, its utility is recognized across various therapeutic areas.

Primarily, this compound is an indispensable precursor in the synthesis of Gefitinib, a targeted therapy used in the treatment of certain types of non-small cell lung cancer. The precise chemical structure of 6,7-Dimethoxy-3,4-dihydroquinazolin-4-one allows for efficient coupling and further functionalization, making it an ideal building block for medicinal chemists. When researchers look to buy this chemical for Gefitinib synthesis, they seek high purity to ensure the efficacy and safety of the final drug product.

Beyond its role as a Gefitinib intermediate, 6,7-Dimethoxy-3,4-dihydroquinazolin-4-one is also employed as a research chemical in broader medicinal chemistry studies. Its quinazolinone core is a common scaffold found in compounds exhibiting various biological activities, including anti-cancer, anti-inflammatory, and antimicrobial properties. Scientists investigating new therapeutic targets often purchase this compound to explore structure-activity relationships (SAR) and to synthesize novel drug candidates.

As a compound that can also appear as a Gefitinib impurity, it serves a critical function as a reference standard for quality control and analytical method development. This dual utility means that reliable suppliers who can provide both high-grade synthesis material and analytical standards are highly sought after.

For scientists looking to procure 6,7-Dimethoxy-3,4-dihydroquinazolin-4-one, partnering with established manufacturers and suppliers offers assurance of quality and consistency. Enquiring about product specifications, including CAS number and purity, is a standard practice. The ability to obtain detailed technical documentation and responsive customer support further enhances the purchasing experience for research professionals.

In summary, 6,7-Dimethoxy-3,4-dihydroquinazolin-4-one is more than just an intermediate; it's a tool that facilitates innovation in drug discovery. By sourcing this compound from reputable manufacturers, research teams can accelerate their development pipelines and contribute to advancements in healthcare.